A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(165 sites)
United States
Local Institution - 2129, Duarte, California Local Institution - 2120, Glendale, California Local Institution - 2136, La Jolla, California Local Institution - 2114, La Jolla, California Local Institution - 2121, Long Beach, California Local Institution - 1001, Orange, California Local Institution - 2101, Orange, California St Joseph Heritage Healthcare, Santa Rosa, California Local Institution - 1003, Aurora, Colorado Local Institution - 2103, Aurora, Colorado Local Institution - 2106, Washington D.C., District of Columbia Local Institution - 2110, Washington D.C., District of Columbia Memorial Healthcare System, Hollywood, Florida Local Institution - 2113, Tampa, Florida University Cancer and Blood Center, Athens, Georgia Local Institution - 2134, Columbus, Georgia University of Chicago, Chicago, Illinois Local Institution - 2142, Peoria, Illinois Local Institution - 2116, New Orleans, Louisiana Local Institution - 2133, Baltimore, Maryland Massachusetts General Hospital,, Boston, Massachusetts Local Institution - 1004, Boston, Massachusetts Local Institution - 2131, Boston, Massachusetts Local Institution - 2105, Ann Arbor, Michigan Local Institution - 2111, Detroit, Michigan Local Institution - 2140, Detroit, Michigan Local Institution - 2132, Saint Paul, Minnesota Local Institution - 2147, Bolivar, Missouri Washington University Infusion Center Pharmacy, St Louis, Missouri Local Institution - 2122, New Brunswick, New Jersey Local Institution - 2117, New York, New York Local Institution - 1002, New York, New York Local Institution - 2102, New York, New York Local Institution - 2144, Goldsboro, North Carolina Local Institution - 2112, Canton, Ohio Local Institution - 2143, Cincinnati, Ohio Local Institution - 2109, Cleveland, Ohio The Ohio State University Wexner Medical Center, Columbus, Ohio Local Institution - 2119, Toledo, Ohio Local Institution - 2108, Philadelphia, Pennsylvania Baptist Memorial Hospital Baptist Cancer Center, Memphis, Tennessee UT Southwestern Medical Center, Dallas, Texas Local Institution - 2127, Houston, Texas MD Anderson Cancer Center, Houston, Texas Local Institution - 2146, Kingwood, Texas Local Institution - 2137, Fairfax, Virginia Local Institution - 2107, Seattle, Washington Local Institution - 2141, Tacoma, Washington Local Institution - 2145, Appleton, Wisconsin Australia
Chris O'Brien LifeHouse, Camperdown, New South Wales Local Institution - 6103, Adelaide, South Australia Peter MacCallum Cancer Centre, Melbourne, Victoria Local Institution - 3301, East Melbourne Belgium
Local Institution - 4802, Antwerp Local Institution - 4801, Leuven Canada
Local Institution - 2202, Edmonton, Alberta Local Institution - 2205, Vancouver, British Columbia Local Institution - 2201, Toronto, Ontario Local Institution - 6503, Toronto, Ontario Local Institution - 2203, Ontario Local Institution - 2204, Ottawa China
Local Institution - 6702, Beijing, Beijing Municipality Beijing Cancer hospital, Beijing, Beijing Municipality Daping Hospital, the Third Affiliated Hospital of Third Military Medical University /Cancer Center, Daping, Chongqing Municipality Local Institution - 6719, Fuzhou, Fujian The First Affiliated hospital of Xiamen University-oncology, Xiamen, Fujian Guangdong Provincial People'S Hospital, Guangzhou, Guangdong Local Institution - 6733, Guangzhou, Guangdong Local Institution - 6505, Shenzhen, Guangdong The Affiliated Tumor Hospital of Harbin Medical University, Harbin, Heilongjiang Local Institution - 6504, Shatin, HONG KONG Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology/Cancer Center Department, Wuhan, Hubei Local Institution - 6705, Changsha, Hunan Denmark
Local Institution - 4901, Copenhagen France
Local Institution - 4201, Marseille, Bouches-du-Rhône Local Institution - 4207, Brest Centre Georges-Francois Leclerc, Dijon Centre Hospitalier Universitarie Grenoble Alpes (Chuga), Grenoble Centre Antoine-Lacassagne, Nice Local Institution - 4208, Poitiers Local Institution - 4203, Saint-Mandé Institute Gustave Roussy, Villejuif Germany
Local Institution - 4704, Berlin Local Institution - 4701, Cologne Local Institution - 4703, Dresden Local Institution - 4702, Heidelberg Hong Kong
Local Institution - 6502, Hong Kong Local Institution - 6501, Hong Kong Hungary
Local Institution - 5101, Budapest Local Institution - 5103, Budapest Italy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, MI Local Institution - 4306, Milan Local Institution - 4307, Palermo Centro di Riferimento Oncologico, Pordenone Local Institution - 4304, Ravenna Local Institution - 4305, Reggio Emilia IRCCS Istituto Regina Elena Oncologia Medica 2, Roma Local Institution - 4302, Terni Japan
Ehime University Hospital, Tōon, Ehime Hokkaido University Hospital, Sapporo, Hokkaido Kanagawa cancer center, Yokohama, Kanagawa Osaka City General Hospital, Osaka, Osaka National Cancer Center Hospital., Chuo-ku, Tokyo Tottori University Hospital, Yonago, Tottori National Cancer Center Hospital East, Kashiwa Nagoya University Hospital, Nagoya Osaka International Cancer institute, Osaka Netherlands
Local Institution - 4502, Amsterdam Local Institution - 4501, Groningen Poland
Ośrodek Badań Klinicznych Wczesnych Faz, Uniwersyteckie Centrum Kliniczne, Gdansk Local Institution - 4604, Lublin Local Institution - 4605, Poznan Local Institution - 4603, Szczecin Local Institution - 4602, Warsaw Singapore
National University Hospital, Singapore National Cancer Center Singapore, Singapore South Korea
Local Institution - 3003, Seoul, Gangnam-gu Chonnam National University Hwasun Hospital, Hwasun-eup, Hwasun-gun, Jeollanam-do Local Institution - 3002, Seoul, Seodaemun-gu Local Institution - 3002, Seoul, Seoul Teugbyeolsi Seoul National University Hospital, Seoul, Seoul-teukbyeolsi [Seoul] Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul] Local Institution - 6306, Cheongju-si Local Institution - 3001, Seoul Yonsei University Health System, Severance Hospital, Seoul Local Institution - 6307, Seoul Asan Medical Center, Seoul Local Institution - 6304, Seoul Spain
Local Institution - 4102, Barcelona Hospital Unversitario Val D'Hebrón, Barcelona Local Institution - 4106, Madrid Local Institution - 4103, Madrid Hospital Universitario HM Sanchinarro CIOCC, Madrid Local Institution - 4108, Pamplona Local Institution - 4107, Valencia Taiwan
Local Institution - 6201, Taiepi Local Institution - 6203, Tainan Local Institution - 6202, Taipei United Kingdom
Local Institution - 4401, London Local Institution - 4402, London Local Institution - 4404, London Local Institution - 4403, Manchester Local Institution - 4405, Sutton Hunan Cancer Hospital-thoracic oncology II, Changsha, Hunan
Local Institution - 6748, Nanjing, Jiangsu XuZhou Central Hospital/Oncology Department, Xuzhou, Jiangsu Jilin Cancer Hospital/Medical Oncology Department, Changchun, Jilin Jilin Cancer Hospital/Medical Oncology Department, Changchun, Jilin The first hospital of Jilin university-Oncology Department, Changchun, Jilin Liaoning Cancer Hospital, Shenyang, Liaoning Tangdu Hospital, Xi'an, Shan3xi Shanxi Bethune Hospital, Taiyuan, Shanxi Sichuan Cancer Hospital/Medical Oncology Department, Chengdu, Sichuan The First Hospital Affiliated To AMU - Southwest Hospital, Chongqing, Sichuan Local Institution - 6725, Hangzhou, Zhejiang Zhejiang Cancer Hospital-Oncology, Hangzhou, Zhejiang The Third Xiangya Hospital of Central South University/Department of Respiratory and Critical Care Medicine, Changsha West China Hospital Sichuan University/Lung cancer center, Chengdu The First Affiliated Hospital - Zhejiang University School of Medicine, Hangzhou Anhui Provincial Hospital, Hefei Shanghai Chest Hospital, Shanghai Shanghai Chest Hospital, Shanghai Weifang People's Hospital/Medical Oncology Department, Weifang Henan Cancer Hospital/The 1st pneumology department, Zhengzhou Age range
12 Years and older